Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by langostaon Feb 20, 2018 11:04am
89 Views
Post# 27587253

RE:RE:RE:RE:RE:RE:RE:RE:So tell me how to identify

RE:RE:RE:RE:RE:RE:RE:RE:So tell me how to identify
Madheights wrote: This is to the investors advantage.  Speculators might not like it as they take what they can off of volitility.  But "cancer" is a word that everyone of us can, in some way shape or form, relate to.  I think it safe to say that regardless of how one feels about TLT, cancer is a disease we all wish was not so.  So, however this plays out, for the sake of those who have risked themselves by participating in the trial and for those who wish they could,  the only outcome they need....is truth.  And whether we like it or not, ultimately...good or bad...because of the consequence how this science may potentially affect of all our lives....I prefer that the share price reflect the same.


I am sure that the bashers feel the same way about cancer as we long investors do. 
 However for them it is somewhat like one Mafia soldier to another.
 
" Hey, no hard feelings, it ain't personal, just business".  Bang!!





Bullboard Posts